为什么一些omega-3脂肪酸治疗心血管疾病的试验结果不一致?

Q Medicine

Clinical Lipidology Pub Date : 2015-02-01 DOI:10.2217/clp.15.1

N. Shaikh, P. Tappia

引用次数: 10

摘要

摘要:“在最近的临床试验和荟萃分析中，人们对omega-3多不饱和脂肪酸治疗心血管疾病的功效提出了一些质疑。”

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Why are there inconsistencies in the outcomes of some omega-3 fatty acid trials for the management of cardiovascular disease?

Abstract “With mixed results in recent clinical trials and meta-analyses some doubt has been raised on the efficacy of omega-3 polyunsaturated fatty acidsfor management of cardiovascular disease.”

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Lipidology 生物-生化与分子生物学

CiteScore

0.44

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism. The Journal''s readership encompasses a broad cross-section of the medical community, including cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity. The Journal also addresses allied health professionals who treat the patient base described above, such as pharmacists, nurse practitioners and dietitians. Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.